Literature DB >> 23733636

Dopamine and renal function and blood pressure regulation.

Ines Armando1, Van Anthony M Villar, Pedro A Jose.   

Abstract

Dopamine is an important regulator of systemic blood pressure via multiple mechanisms. It affects fluid and electrolyte balance by its actions on renal hemodynamics and epithelial ion and water transport and by regulation of hormones and humoral agents. The kidney synthesizes dopamine from circulating or filtered L-DOPA independently from innervation. The major determinants of the renal tubular synthesis/release of dopamine are probably sodium intake and intracellular sodium. Dopamine exerts its actions via two families of cell surface receptors, D1-like receptors comprising D1R and D5R, and D2-like receptors comprising D2R, D3R, and D4R, and by interactions with other G protein-coupled receptors. D1-like receptors are linked to vasodilation, while the effect of D2-like receptors on the vasculature is variable and probably dependent upon the state of nerve activity. Dopamine secreted into the tubular lumen acts mainly via D1-like receptors in an autocrine/paracrine manner to regulate ion transport in the proximal and distal nephron. These effects are mediated mainly by tubular mechanisms and augmented by hemodynamic mechanisms. The natriuretic effect of D1-like receptors is caused by inhibition of ion transport in the apical and basolateral membranes. D2-like receptors participate in the inhibition of ion transport during conditions of euvolemia and moderate volume expansion. Dopamine also controls ion transport and blood pressure by regulating the production of reactive oxygen species and the inflammatory response. Essential hypertension is associated with abnormalities in dopamine production, receptor number, and/or posttranslational modification.
© 2011 American Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 23733636      PMCID: PMC6342207          DOI: 10.1002/cphy.c100032

Source DB:  PubMed          Journal:  Compr Physiol        ISSN: 2040-4603            Impact factor:   9.090


  49 in total

1.  NHERF-1 and the regulation of renal phosphate reabsoption: a tale of three hormones.

Authors:  Edward J Weinman; Eleanor D Lederer
Journal:  Am J Physiol Renal Physiol       Date:  2012-04-25

2.  Dopamine D3 Receptor Antagonist (GSK598809) Potentiates the Hypertensive Effects of Cocaine in Conscious, Freely-Moving Dogs.

Authors:  Nathan M Appel; Shou-Hua Li; Tyson H Holmes; Jane B Acri
Journal:  J Pharmacol Exp Ther       Date:  2015-07-15       Impact factor: 4.030

3.  Dopamine D2 receptors' effects on renal inflammation are mediated by regulation of PP2A function.

Authors:  Yanrong Zhang; Xiaoliang Jiang; Chuan Qin; Santiago Cuevas; Pedro A Jose; Ines Armando
Journal:  Am J Physiol Renal Physiol       Date:  2015-08-19

4.  Newly Developed Dopamine D3 Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats.

Authors:  Chloe J Jordan; Bree A Humburg; Eric B Thorndike; Anver Basha Shaik; Zheng-Xiong Xi; Michael H Baumann; Amy Hauck Newman; Charles W Schindler
Journal:  J Pharmacol Exp Ther       Date:  2019-09-27       Impact factor: 4.030

5.  Sorting nexin 5 and dopamine d1 receptor regulate the expression of the insulin receptor in human renal proximal tubule cells.

Authors:  Fengmin Li; Jian Yang; John Edward Jones; Van Anthony M Villar; Peiying Yu; Ines Armando; Robin A Felder; Pedro A Jose
Journal:  Endocrinology       Date:  2015-03-31       Impact factor: 4.736

6.  Lipid rafts are required for effective renal D1 dopamine receptor function.

Authors:  Andrew C Tiu; Jian Yang; Laureano D Asico; Prasad Konkalmatt; Xiaoxu Zheng; Santiago Cuevas; Xiaoyan Wang; Hewang Lee; Momina Mazhar; Robin A Felder; Pedro A Jose; Van Anthony M Villar
Journal:  FASEB J       Date:  2020-04-07       Impact factor: 5.191

7.  Dopamine D1 and D5 receptors differentially regulate oxidative stress through paraoxonase 2 in kidney cells.

Authors:  S Yang; Y Yang; P Yu; J Yang; X Jiang; V A M Villar; D R Sibley; P A Jose; C Zeng
Journal:  Free Radic Res       Date:  2015-03-05

8.  Loss of NHERF-1 expression prevents dopamine-mediated Na-K-ATPase regulation in renal proximal tubule cells from rat models of hypertension: aged F344 rats and spontaneously hypertensive rats.

Authors:  Michelle T Barati; Corey J Ketchem; Michael L Merchant; Walter B Kusiak; Pedro A Jose; Edward J Weinman; Amanda J LeBlanc; Eleanor D Lederer; Syed J Khundmiri
Journal:  Am J Physiol Cell Physiol       Date:  2017-05-17       Impact factor: 4.249

9.  Sorting nexin 1 loss results in increased oxidative stress and hypertension.

Authors:  Jian Yang; Laureano D Asico; Amber L Beitelshees; Jun B Feranil; Xiaoyan Wang; John E Jones; Ines Armando; Santiago G Cuevas; Gary L Schwartz; John G Gums; Arlene B Chapman; Stephen T Turner; Eric Boerwinkle; Rhonda M Cooper-DeHoff; Julie A Johnson; Robin A Felder; Edward J Weinman; Chunyu Zeng; Pedro A Jose; Van Anthony M Villar
Journal:  FASEB J       Date:  2020-04-15       Impact factor: 5.191

10.  First D1-like receptor PET imaging of the rat and primate kidney: implications for human disease monitoring.

Authors:  Michael L Granda; Frederick A Schroeder; Ronald H J Borra; Nathan Schauer; Ehimen Aisaborhale; Alexander R Guimaraes; Jacob M Hooker
Journal:  Am J Physiol Renal Physiol       Date:  2014-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.